CTOR (Citius Oncology) Inventories, Finished Goods: $15.71 Mil (As of Mar. 2026)


CTOR Citius Oncology Inc CTOR
10 GF Score
Price $0.65
! 2 Warning Signs
View Full Analysis

What is Citius Oncology Inventories, Finished Goods?

Citius Oncology CTOR -7.12% 10 Inventories, Finished Goods is $15.71 Mil as of Mar. 2026. GuruFocus rates CTOR with a GF Score™ of 10/100. The stock has 2 warning signs investors should review.

Citius Oncology's quarterly finished goods increased from Sep. 2025 ($10.58 Mil) to Dec. 2025 ($15.69 Mil) and increased from Dec. 2025 ($15.69 Mil) to Mar. 2026 ($15.71 Mil).

Citius Oncology's annual finished goods increased from Sep. 2023 ($0.00 Mil) to Sep. 2024 ($6.14 Mil) and increased from Sep. 2024 ($6.14 Mil) to Sep. 2025 ($10.58 Mil).

Citius Oncology Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Citius Oncology's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Citius Oncology Inventories, Finished Goods Chart

Citius Oncology Annual Data
Trend Sep22 Sep23 Sep24 Sep25
Inventories, Finished Goods
0.00 0.00 6.14 10.58

Citius Oncology Quarterly Data
Sep22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 10.58 15.69 15.71
CTOR
10GF Score
Citius Oncology Inc CTOR
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Citius Oncology Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of $15.71 Mil mean?
Citius Oncology (CTOR) has a Inventories, Finished Goods of $15.71 Mil as of Mar. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on Citius Oncology and its competitors.
Is Citius Oncology's Inventories, Finished Goods too high?
Citius Oncology's current Inventories, Finished Goods is $15.71 Mil. Overall, Citius Oncology has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Citius Oncology's Inventories, Finished Goods compare to INCR and TLPH?
Citius Oncology's Inventories, Finished Goods of $15.71 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Drug Manufacturers company?
A good Inventories, Finished Goods depends on the Drug Manufacturers industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Citius Oncology and its competitors. Citius Oncology's current Inventories, Finished Goods is $15.71 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Citius Oncology stock overvalued right now?
Citius Oncology (CTOR) has a current Inventories, Finished Goods of $15.71 Mil. The current Inventories, Finished Goods is $15.71 Mil. Citius Oncology's overall GF Score™ is 10/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Citius Oncology (CTOR), the current Inventories, Finished Goods is $15.71 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Citius Oncology Business Description

Address 11 Commerce Drive, First Floor, Cranford, NY, USA, 07016
Citius Oncology Inc is a biopharmaceutical company focused on developing and commercializing targeted oncology therapies.The Company centers on achieving a market position by advancing therapies with reduced development and clinical risks, and competitive advantages supported by intellectual property and regulatory exclusivity protection. This includes new formulations of previously approved drugs with substantial existing safety and efficacy data or expanded indications for approved therapies. The company focused on key geographies and stakeholders, majorly on cancer centers and patients.
10GF Score

Get the complete analysis for CTOR

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.65
Price